These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. Kappas A; Drummond GS; Munson DP; Marshall JR Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664 [TBL] [Abstract][Full Text] [Related]
8. Single versus double volume exchange transfusion in jaundiced newborn infants. Thayyil S; Milligan DW Cochrane Database Syst Rev; 2006 Oct; (4):CD004592. PubMed ID: 17054210 [TBL] [Abstract][Full Text] [Related]
9. Blood transfusion therapy in the newborn. Carapella De Luca E; Stegagno M Haematologia (Budap); 1981; 14(2):173-90. PubMed ID: 7024055 [TBL] [Abstract][Full Text] [Related]
10. [Evolution of neonatal transfusion practices: current recommendations]. Plaisant F Transfus Clin Biol; 2011 Apr; 18(2):262-8. PubMed ID: 21440478 [TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
12. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Drews RE Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693 [TBL] [Abstract][Full Text] [Related]
13. The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation. Wang Z; Sorror ML; Leisenring W; Schoch G; Maloney DG; Sandmaier BM; Storb R Br J Haematol; 2010 Apr; 149(1):101-10. PubMed ID: 20067562 [TBL] [Abstract][Full Text] [Related]
14. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease]. Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S; Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397 [TBL] [Abstract][Full Text] [Related]
15. Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn? Ree IMC; van 't Oever RM; Zwiers C; Verweij EJT; Oepkes D; de Haas M; Lopriore E Am J Obstet Gynecol MFM; 2021 May; 3(3):100332. PubMed ID: 33609759 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia. Mohan P; Brocklehurst P Cochrane Database Syst Rev; 2003; (4):CD003956. PubMed ID: 14584000 [TBL] [Abstract][Full Text] [Related]
17. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Aher SM; Ohlsson A Cochrane Database Syst Rev; 2014 Apr; (4):CD004868. PubMed ID: 24760628 [TBL] [Abstract][Full Text] [Related]
18. Exchange transfusion in neonatal hyperbilirubinaemia: a comparison between citrated whole blood and reconstituted blood. Gharehbaghi MM; Hosseinpour SS Singapore Med J; 2010 Aug; 51(8):641-4. PubMed ID: 20848061 [TBL] [Abstract][Full Text] [Related]
19. Blood transfusion: merits of component therapy. I. The clinical use of red cells, platelets, and granulocytes. Buchholz DH J Pediatr; 1974 Jan; 84(1):1-15. PubMed ID: 12119922 [No Abstract] [Full Text] [Related]
20. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology; 1996 Mar; 84(3):732-47. PubMed ID: 8659805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]